Tectonic Therapeutic (TECX) Operating Expenses (2017 - 2026)

Tectonic Therapeutic (TECX) has reported Operating Expenses for 10 consecutive years, with $27.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Expenses rose 49.2% year-over-year to $27.3 million; the TTM figure through Mar 2026 stood at $93.0 million (up 46.87% YoY), while the FY2025 annual figure was $84.0 million, up 44.85% from the prior year.
• Operating Expenses grew to $27.3 million in Q1 2026 per TECX's latest filing, from $21.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $29.4 million in Q1 2022 and bottomed at $9.4 million in Q4 2023.
• Historically, Operating Expenses has averaged $19.4 million across 5 years, with a median of $21.5 million in 2025.
• Annual changes were most pronounced in 2023 — Operating Expenses sank 62.89% — and 2025, when it jumped 95.53%.
• Tectonic Therapeutic's Operating Expenses stood at $25.3 million in 2022, then tumbled by 62.89% to $9.4 million in 2023, then jumped by 49.25% to $14.0 million in 2024, then surged by 53.78% to $21.5 million in 2025, then increased by 26.89% to $27.3 million in 2026.
• Business Quant data shows TECX's Operating Expenses at $27.3 million in Q1 2026, $21.5 million in Q4 2025, and $21.9 million in Q3 2025.